glucose News

EKF's Point-of-Care Tests to Continue Using SurgiLance Safety Lancets

For its diabetic supply patients, MyidealCare™ gave its support today to the YMCA’s annual Team Lean weight loss program aimed at duplicating results on the reality TV show, The Biggest Loser, but on the local level.

MyidealCARE™ is showcasing the Fora® V10 compact, newer talking diabetic meters which are less painful to use as they allow alternate site testing (AST) at areas around the body, instead of only using the fingertips for diabetic sampling.

MediPurpose donated 240 boxes of its SurgiLance SL240 safety lancets to Taylor Internal Medicine. The orange safety lancet's 22-gauge blade delivers an incision depth of 2.2 mm and is ideal for 20-40 µL blood collections.

An automated on/off feature built into insulin pump systems can suspend insulin delivery when it detects low blood glucose levels, significantly reducing the severity and duration of hypoglycemia in individuals with type 1 diabetes.

Piribo, the online destination for Pharma intelligence, has added a new report.

EKF's Point-of-Care Tests to Continue Using SurgiLance Safety Lancets

For its diabetic supply patients, MyidealCare™ gave its support today to the YMCA’s annual Team Lean weight loss program aimed at duplicating results on the reality TV show, The Biggest Loser, but on the local level.

MyidealCARE™ is showcasing the Fora® V10 compact, newer talking diabetic meters which are less painful to use as they allow alternate site testing (AST) at areas around the body, instead of only using the fingertips for diabetic sampling.

According to Vice Chairman of CSA, China's output of sucrose may reach 12 million tonnes in the extraction season of 2011/2012, which may slow down the fast development of starch sugar.

TechNavio today launched its report, Global Glucose Monitoring Device Market 2010-2014, which is based on an in-depth study of the Americas and the EMEA and APAC regions.

MediPurpose donated 240 boxes of its SurgiLance SL240 safety lancets to Taylor Internal Medicine. The orange safety lancet's 22-gauge blade delivers an incision depth of 2.2 mm and is ideal for 20-40 µL blood collections.

Although domestic production output of sugar alcohol is high, its raw material supply is tight. It is indicated that production cost of sugar alcohol is rising.

MediPurpose was among exhibitors that hosted booths for diabetes patients and healthcare professionals. The SurgiLance booth provided no-cost product samples and educational resources concerning SurgiLance safety lancets.

Aarkstore announce a new report "Continuous Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 " through its vast collection of market research report.

After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.

Virtually every health store offers a wide selection of weight-loss supplements. Do they all work? No. Many companies make good money off of people’s obsession with dropping pounds.

HealthSaaS today announced the release of Glucose Tracker Plus for Windows Phone 7 with connectivity to Microsoft HealthVault.

Stronger diabetes education and awareness leads to increase market growth for Thailand's SMBG devices market

New Medical Devices market report from GlobalData: "Xhale Diagnostics, Inc. - Product Pipeline Analysis"

Bharatbook added a new report on "Glucose Monitoring Devices Market Worldwide (2010 - 2014)" which gives the emerging key players in the Glucose Monitoring Devices Market.

New Medical Devices research report from GlobalData is now available from Fast Market Research

Fast Market Research recommends "Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platform for Closed Loop System - Deal Analysis from GlobalData" from GlobalData, now available

Gene-Eden, an all-natural anti-viral dietary supplement, can reduce cholesterol and glucose levels and strengthen the immune system. The following is a review of a satisfied customer who lowered his cholesterol to healthy levels with use of Gene-Eden

The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long term diabetic control than blood glucose.

Fast Market Research recommends "Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016" from GlobalData, now available

Fast Market Research recommends "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC)" from Markets and Markets, now available

High blood pressure in some pregnancies can be a predictor of future heart issues in certain women. Now it seems that gestational diabetes can also be an indicator of who will get the full blown diabetes disease later in life.

New Medical Devices market report from GlobalData: "United Kingdom Diabetes Care Devices Market Outlook to 2016"

Recently published research from GlobalData, "Argentina Diabetes Care Devices Market Outlook to 2016", is now available at Fast Market Research

New Medical Devices research report from GlobalData is now available from Fast Market Research

Nova Biomedical’s StatStrip® Xpress™ glucose monitor has been granted CLIA-waived status from the U.S. Food and Drug Administration

Coping with Diabetes can be a very difficult struggle but now there is hope with a new solution to the problem which could cure millions of sufferers world wide

California federal jury awards complete victory to Nova Biomedical Corporation against Medtronic MiniMed, Inc., for claims of misappropriation of trade secrets, breach of contract, tortuous interference and conversion.

Revitance Nutrition 七月在台灣上市了新產品 「惟饌特殊配方營養品」，「惟饌特殊配方營養品」是為糖尿病患設計的營養均衡配方奶粉，可取代一餐、做為健康的點心或管灌飲食。

Revitance Nutrition launches a special diabetes formula in Taiwan starting July this year. The product, called Revitance Diabetes (Chinese name 惟饌特殊配方營養品) is a balanced nutritional formula for people with diabetes.

Gestational Diabetes is a type of diabetes which is only suffered by pregnant women. This diabetes always develops during the 24th to 28th weeks of pregnancy. Mother and her baby might gain a greater risk for complications at the time of delivery.

Diabetes Type 1 is a serious chronic disorder which usually develops in childhood or adolescence, but can also occur in adulthood. Type 1 Diabetes is an inherited disease, thus people with a family history of it are at greatest risk.

Bharatbook.com added a new report on "Global Self Monitoring Blood Glucose Market SMBG Increasing Adoption to Drive Growth" identifies the key trends shaping and driving the dynamism in the global SMBG market.

Revitance Nutrition launches a special diabetes nutrition in the Philippines as per June this year. The product, called Revitance Diabetes, is a balanced nutritional formula for people with diabetes.

The global diabetes care devices market was valued at $12.9 billion in 2008. Driven by increasing affordability of home diagnostics and the increasing incidence of the diabetic population around the world, ...

A new web community has been formed for people who have diabetes. This website offers users daily support, forums,easy menus, latest Diabetes news and even a secure place to keep health records that can be printed and taken to their doctor.

Enter A1c scores and calculate average glucose on your iPhone. If you have an A1c goal, enter your glucose scores to calculate A1c value. The red blood cell slider allows you to see the connection between A1c values and average glucose scores.

The global self monitoring blood glucose market is forecast to grow from $9,578 million in 2008 to $19,685 million in 2015 with an annual growth rate of 10.8%

Global Markets Direct’s “The Future of the Diabetes Care Devices Market to 2015” report provides market landscape, competitive landscape and market trends information on the glucose monitoring and insulin delivery markets.